世界の真核生物発現システム市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Eukaryotic Expression Systems Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2260
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、真核生物発現システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬、発現ベクター、コンピテントセル）、用途別市場規模（細菌発現システム、酵母発現システム、昆虫発現システム、哺乳類発現システム）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・真核生物発現システムの市場動向
・企業の競争状況、市場シェア
・真核生物発現システムの種類別市場規模（試薬、発現ベクター、コンピテントセル）
・真核生物発現システムの用途別市場規模（細菌発現システム、酵母発現システム、昆虫発現システム、哺乳類発現システム）
・真核生物発現システムの北米市場規模2016-2027（アメリカ、カナダ）
・真核生物発現システムのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・真核生物発現システムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・真核生物発現システムの中南米市場規模2016-2027（メキシコ、ブラジル）
・真核生物発現システムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Thermo Fisher、Sigma Aldrich、Jena Bioscience、New England Biolabs、Takara Bio、Bio Rad、Promega、Agilent、Merck Millipore）
・結論

Market Analysis and Insights: Global Eukaryotic Expression Systems Market
The global Eukaryotic Expression Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eukaryotic Expression Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eukaryotic Expression Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eukaryotic Expression Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eukaryotic Expression Systems market.

Global Eukaryotic Expression Systems Scope and Market Size
Eukaryotic Expression Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eukaryotic Expression Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Reagents
Expression vectors
Competent cells

Segment by Application
Bacterial Expression System
Yeast Expression System
Insect Expression System
Mammalian Expression System

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher
Sigma Aldrich
Jena Bioscience
New England Biolabs
Takara Bio
Bio Rad
Promega
Agilent
Merck Millipore

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eukaryotic Expression Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reagents
1.2.3 Expression vectors
1.2.4 Competent cells
1.3 Market by Application
1.3.1 Global Eukaryotic Expression Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bacterial Expression System
1.3.3 Yeast Expression System
1.3.4 Insect Expression System
1.3.5 Mammalian Expression System
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Eukaryotic Expression Systems Market Perspective (2016-2027)
2.2 Eukaryotic Expression Systems Growth Trends by Regions
2.2.1 Eukaryotic Expression Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Eukaryotic Expression Systems Historic Market Share by Regions (2016-2021)
2.2.3 Eukaryotic Expression Systems Forecasted Market Size by Regions (2022-2027)
2.3 Eukaryotic Expression Systems Industry Dynamic
2.3.1 Eukaryotic Expression Systems Market Trends
2.3.2 Eukaryotic Expression Systems Market Drivers
2.3.3 Eukaryotic Expression Systems Market Challenges
2.3.4 Eukaryotic Expression Systems Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Eukaryotic Expression Systems Players by Revenue
3.1.1 Global Top Eukaryotic Expression Systems Players by Revenue (2016-2021)
3.1.2 Global Eukaryotic Expression Systems Revenue Market Share by Players (2016-2021)
3.2 Global Eukaryotic Expression Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Eukaryotic Expression Systems Revenue
3.4 Global Eukaryotic Expression Systems Market Concentration Ratio
3.4.1 Global Eukaryotic Expression Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eukaryotic Expression Systems Revenue in 2020
3.5 Eukaryotic Expression Systems Key Players Head office and Area Served
3.6 Key Players Eukaryotic Expression Systems Product Solution and Service
3.7 Date of Enter into Eukaryotic Expression Systems Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Eukaryotic Expression Systems Breakdown Data by Type
4.1 Global Eukaryotic Expression Systems Historic Market Size by Type (2016-2021)
4.2 Global Eukaryotic Expression Systems Forecasted Market Size by Type (2022-2027)

5 Eukaryotic Expression Systems Breakdown Data by Application
5.1 Global Eukaryotic Expression Systems Historic Market Size by Application (2016-2021)
5.2 Global Eukaryotic Expression Systems Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Eukaryotic Expression Systems Market Size (2016-2027)
6.2 North America Eukaryotic Expression Systems Market Size by Type
6.2.1 North America Eukaryotic Expression Systems Market Size by Type (2016-2021)
6.2.2 North America Eukaryotic Expression Systems Market Size by Type (2022-2027)
6.2.3 North America Eukaryotic Expression Systems Market Size by Type (2016-2027)
6.3 North America Eukaryotic Expression Systems Market Size by Application
6.3.1 North America Eukaryotic Expression Systems Market Size by Application (2016-2021)
6.3.2 North America Eukaryotic Expression Systems Market Size by Application (2022-2027)
6.3.3 North America Eukaryotic Expression Systems Market Size by Application (2016-2027)
6.4 North America Eukaryotic Expression Systems Market Size by Country
6.4.1 North America Eukaryotic Expression Systems Market Size by Country (2016-2021)
6.4.2 North America Eukaryotic Expression Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Eukaryotic Expression Systems Market Size (2016-2027)
7.2 Europe Eukaryotic Expression Systems Market Size by Type
7.2.1 Europe Eukaryotic Expression Systems Market Size by Type (2016-2021)
7.2.2 Europe Eukaryotic Expression Systems Market Size by Type (2022-2027)
7.2.3 Europe Eukaryotic Expression Systems Market Size by Type (2016-2027)
7.3 Europe Eukaryotic Expression Systems Market Size by Application
7.3.1 Europe Eukaryotic Expression Systems Market Size by Application (2016-2021)
7.3.2 Europe Eukaryotic Expression Systems Market Size by Application (2022-2027)
7.3.3 Europe Eukaryotic Expression Systems Market Size by Application (2016-2027)
7.4 Europe Eukaryotic Expression Systems Market Size by Country
7.4.1 Europe Eukaryotic Expression Systems Market Size by Country (2016-2021)
7.4.2 Europe Eukaryotic Expression Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Eukaryotic Expression Systems Market Size (2016-2027)
8.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Type
8.2.1 Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Eukaryotic Expression Systems Market Size by Application
8.3.1 Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Eukaryotic Expression Systems Market Size by Region
8.4.1 Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Eukaryotic Expression Systems Market Size (2016-2027)
9.2 Latin America Eukaryotic Expression Systems Market Size by Type
9.2.1 Latin America Eukaryotic Expression Systems Market Size by Type (2016-2021)
9.2.2 Latin America Eukaryotic Expression Systems Market Size by Type (2022-2027)
9.2.3 Latin America Eukaryotic Expression Systems Market Size by Type (2016-2027)
9.3 Latin America Eukaryotic Expression Systems Market Size by Application
9.3.1 Latin America Eukaryotic Expression Systems Market Size by Application (2016-2021)
9.3.2 Latin America Eukaryotic Expression Systems Market Size by Application (2022-2027)
9.3.3 Latin America Eukaryotic Expression Systems Market Size by Application (2016-2027)
9.4 Latin America Eukaryotic Expression Systems Market Size by Country
9.4.1 Latin America Eukaryotic Expression Systems Market Size by Country (2016-2021)
9.4.2 Latin America Eukaryotic Expression Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Eukaryotic Expression Systems Market Size (2016-2027)
10.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Type
10.2.1 Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Eukaryotic Expression Systems Market Size by Application
10.3.1 Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Eukaryotic Expression Systems Market Size by Country
10.4.1 Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Eukaryotic Expression Systems Introduction
11.1.4 Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.1.5 Thermo Fisher Recent Development
11.2 Sigma Aldrich
11.2.1 Sigma Aldrich Company Details
11.2.2 Sigma Aldrich Business Overview
11.2.3 Sigma Aldrich Eukaryotic Expression Systems Introduction
11.2.4 Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.2.5 Sigma Aldrich Recent Development
11.3 Jena Bioscience
11.3.1 Jena Bioscience Company Details
11.3.2 Jena Bioscience Business Overview
11.3.3 Jena Bioscience Eukaryotic Expression Systems Introduction
11.3.4 Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.3.5 Jena Bioscience Recent Development
11.4 New England Biolabs
11.4.1 New England Biolabs Company Details
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs Eukaryotic Expression Systems Introduction
11.4.4 New England Biolabs Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.4.5 New England Biolabs Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Eukaryotic Expression Systems Introduction
11.5.4 Takara Bio Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.5.5 Takara Bio Recent Development
11.6 Bio Rad
11.6.1 Bio Rad Company Details
11.6.2 Bio Rad Business Overview
11.6.3 Bio Rad Eukaryotic Expression Systems Introduction
11.6.4 Bio Rad Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.6.5 Bio Rad Recent Development
11.7 Promega
11.7.1 Promega Company Details
11.7.2 Promega Business Overview
11.7.3 Promega Eukaryotic Expression Systems Introduction
11.7.4 Promega Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.7.5 Promega Recent Development
11.8 Agilent
11.8.1 Agilent Company Details
11.8.2 Agilent Business Overview
11.8.3 Agilent Eukaryotic Expression Systems Introduction
11.8.4 Agilent Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.8.5 Agilent Recent Development
11.9 Merck Millipore
11.9.1 Merck Millipore Company Details
11.9.2 Merck Millipore Business Overview
11.9.3 Merck Millipore Eukaryotic Expression Systems Introduction
11.9.4 Merck Millipore Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.9.5 Merck Millipore Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Eukaryotic Expression Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Reagents
Table 3. Key Players of Expression vectors
Table 4. Key Players of Competent cells
Table 5. Global Eukaryotic Expression Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Eukaryotic Expression Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Eukaryotic Expression Systems Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Eukaryotic Expression Systems Market Share by Regions (2016-2021)
Table 9. Global Eukaryotic Expression Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Eukaryotic Expression Systems Market Share by Regions (2022-2027)
Table 11. Eukaryotic Expression Systems Market Trends
Table 12. Eukaryotic Expression Systems Market Drivers
Table 13. Eukaryotic Expression Systems Market Challenges
Table 14. Eukaryotic Expression Systems Market Restraints
Table 15. Global Eukaryotic Expression Systems Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Eukaryotic Expression Systems Market Share by Players (2016-2021)
Table 17. Global Top Eukaryotic Expression Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eukaryotic Expression Systems as of 2020)
Table 18. Ranking of Global Top Eukaryotic Expression Systems Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Eukaryotic Expression Systems Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Eukaryotic Expression Systems Product Solution and Service
Table 22. Date of Enter into Eukaryotic Expression Systems Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Eukaryotic Expression Systems Revenue Market Share by Type (2016-2021)
Table 26. Global Eukaryotic Expression Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Eukaryotic Expression Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Eukaryotic Expression Systems Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Eukaryotic Expression Systems Revenue Market Share by Application (2016-2021)
Table 30. Global Eukaryotic Expression Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Eukaryotic Expression Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Company Details
Table 63. Thermo Fisher Business Overview
Table 64. Thermo Fisher Eukaryotic Expression Systems Product
Table 65. Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Recent Development
Table 67. Sigma Aldrich Company Details
Table 68. Sigma Aldrich Business Overview
Table 69. Sigma Aldrich Eukaryotic Expression Systems Product
Table 70. Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 71. Sigma Aldrich Recent Development
Table 72. Jena Bioscience Company Details
Table 73. Jena Bioscience Business Overview
Table 74. Jena Bioscience Eukaryotic Expression Systems Product
Table 75. Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 76. Jena Bioscience Recent Development
Table 77. New England Biolabs Company Details
Table 78. New England Biolabs Business Overview
Table 79. New England Biolabs Eukaryotic Expression Systems Product
Table 80. New England Biolabs Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 81. New England Biolabs Recent Development
Table 82. Takara Bio Company Details
Table 83. Takara Bio Business Overview
Table 84. Takara Bio Eukaryotic Expression Systems Product
Table 85. Takara Bio Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 86. Takara Bio Recent Development
Table 87. Bio Rad Company Details
Table 88. Bio Rad Business Overview
Table 89. Bio Rad Eukaryotic Expression Systems Product
Table 90. Bio Rad Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 91. Bio Rad Recent Development
Table 92. Promega Company Details
Table 93. Promega Business Overview
Table 94. Promega Eukaryotic Expression Systems Product
Table 95. Promega Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 96. Promega Recent Development
Table 97. Agilent Company Details
Table 98. Agilent Business Overview
Table 99. Agilent Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 100. Agilent Recent Development
Table 101. Merck Millipore Company Details
Table 102. Merck Millipore Business Overview
Table 103. Merck Millipore Eukaryotic Expression Systems Product
Table 104. Merck Millipore Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 105. Merck Millipore Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eukaryotic Expression Systems Market Share by Type: 2020 VS 2027
Figure 2. Reagents Features
Figure 3. Expression vectors Features
Figure 4. Competent cells Features
Figure 5. Global Eukaryotic Expression Systems Market Share by Application: 2020 VS 2027
Figure 6. Bacterial Expression System Case Studies
Figure 7. Yeast Expression System Case Studies
Figure 8. Insect Expression System Case Studies
Figure 9. Mammalian Expression System Case Studies
Figure 10. Eukaryotic Expression Systems Report Years Considered
Figure 11. Global Eukaryotic Expression Systems Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Eukaryotic Expression Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Eukaryotic Expression Systems Market Share by Regions: 2020 VS 2027
Figure 14. Global Eukaryotic Expression Systems Market Share by Regions (2022-2027)
Figure 15. Global Eukaryotic Expression Systems Market Share by Players in 2020
Figure 16. Global Top Eukaryotic Expression Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eukaryotic Expression Systems as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Eukaryotic Expression Systems Revenue in 2020
Figure 18. Global Eukaryotic Expression Systems Revenue Market Share by Type (2016-2021)
Figure 19. Global Eukaryotic Expression Systems Revenue Market Share by Type (2022-2027)
Figure 20. North America Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 22. North America Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 23. North America Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 24. United States Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 28. Europe Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 29. Europe Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 30. Germany Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Eukaryotic Expression Systems Market Share by Region (2016-2027)
Figure 40. China Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 48. Latin America Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 49. Latin America Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 50. Mexico Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 56. Turkey Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 60. Sigma Aldrich Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 61. Jena Bioscience Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 62. New England Biolabs Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 63. Takara Bio Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 64. Bio Rad Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 65. Promega Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 66. Agilent Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 67. Merck Millipore Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のレンチウイルス発現システム市場規模・現状・予測（2021年-2027年）

Global Lentiviral Expression Systems Market Size, Status and Forecast 2021-2027
QYR2104Z3399 2021年4月 97Pages
QYResearch社発行の本調査資料では、レンチウイルス発現システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（レンチウイルスプロモーター、レンチウイルス融合タグ、レンチウイルスパッケージングシステム、その他）、用途別市場規模（バイオテク...

世界の遺伝子発現市場規模・現状・予測（2021年-2027年）

Global Gene Expression Market Size, Status and Forecast 2021-2027
QYR2104Z2512 2021年4月 98Pages
QYResearch社発行の本調査資料では、遺伝子発現のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、機器）、用途別市場規模（創薬、診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中...

世界のタンパク質発現技術市場規模・現状・予測（2021年-2027年）

Global Protein Expression Technology Market Size, Status and Forecast 2021-2027
QYR2104Z4842 2021年4月 98Pages
QYResearch社発行の本調査資料では、タンパク質発現技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（発現ベクター、コンピテントセル、試薬、機器）、用途別市場規模（製薬会社、学術研究機関、委託研究機関、バイオテクノロジー会社）、主要地域...

世界の発現ベクター市場規模・現状・予測（2021年-2027年）

Global Expression Vectors Market Size, Status and Forecast 2021-2027
QYR2104Z2278 2021年4月 99Pages
QYResearch社発行の本調査資料では、発現ベクターのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バクテリア、哺乳類、酵母、昆虫）、用途別市場規模（遺伝、分子生物学、バイオインフォマティクス、アンメットメディカルニーズ）、主要地域別市場規...

世界のORF発現クローン市場規模・現状・予測（2021年-2027年）

Global ORF Expression Clones Market Size, Status and Forecast 2021-2027
QYR2104Z4308 2021年4月 91Pages
QYResearch社発行の本調査資料では、ORF発現クローンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（哺乳類発現系、レンチウイルス発現系、細菌発現系、酵母発現系、昆虫、小麦胚芽細胞、その他）、用途別市場規模（バイオテクノロジー企業、製薬...

世界のタンパク質発現市場規模・現状・予測（2021年-2027年）

Global Protein Expression Market Size, Status and Forecast 2021-2027
QYR2104Z4841 2021年4月 92Pages
QYResearch社発行の本調査資料では、タンパク質発現のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬、発現ベクター、コンピテントセル、機器、サービス）、用途別市場規模（治療、研究、産業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のIn Vitroタンパク質発現市場規模・現状・予測（2021年-2027年）

Global In Vitro Protein Expression Market Size, Status and Forecast 2021-2027
QYR2104Z3075 2021年4月 99Pages
QYResearch社発行の本調査資料では、In Vitroタンパク質発現のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（酵母発現、哺乳類発現、藻類発現、昆虫発現、細菌発現、無細胞発現）、用途別市場規模（細胞培養、タンパク質精製、膜タンパク質、...

世界の哺乳動物一過性タンパク質発現市場規模・現状・予測（2021年-2027年）

Global Mammalian Transient Protein Expression Market Size, Status and Forecast 2021-2027
QYR2104Z3547 2021年4月 99Pages
QYResearch社発行の本調査資料では、哺乳動物一過性タンパク質発現のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、発現ベクター、試薬・消耗品、その他）、用途別市場規模（委託研究機関、バイオ医薬品企業、学術・研究機関）、主要地域別市場...

世界の哺乳動物一過性タンパク質発現市場規模・現状・予測（2021年-2027年）

世界の発現用コンピテントセル市場規模・現状・予測（2021年-2027年）

Global Expression Competent Cells Market Size, Status and Forecast 2021-2027
QYR2104Z2277 2021年4月 130Pages
QYResearch社発行の本調査資料では、発現用コンピテントセルのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学的コンピテントセル、電子的コンピテントセル）、用途別市場規模（タンパク質発現、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の発現ベクター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Expression Vectors Market The global Expression Vectors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
世界のORF発現クローン市場規模・現状・予測（2021年-2027年） The ORF expression clones are plasmid that contains protein coding DNA, the DNA contains the coding sequence without 5' and 3' end untranslated regions. The ORF expression clones helps to save as it moves directly protein expression and protein analysis. North America is estimated to lead the global…
世界のタンパク質発現技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Protein Expression Technology Market The global Protein Expression Technology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界のレンチウイルス発現システム市場規模・現状・予測（2021年-2027年） Lentiviral are vectors that are derived from the virus known as human immunodeficiency virus and is used to transfer gene in the cells, such as mammalian cell and others. Lentiviruses are used for transfection in non-dividing and actively dividing cell. This acts as an advantage to another type of r…
世界の哺乳動物一過性タンパク質発現市場規模・現状・予測（2021年-2027年） The use of mammalian transient protein expression in quick production of proteins continues to spur developments. The capability of mammalian cells to aid development of proteins with similar bioactivity as natural proteins continues to boost their adoption. Market Analysis and Insights: Global Mamm…